Cost‐effectiveness analysis of low‐dose direct oral anticoagulant (DOAC) for the prevention of cancer‐associated thrombosis in the United States
Journal article published in 2020 by
Ang Li 
,
Josh J. Carlson ,
Nicole M. Kuderer,
Jordan K. Schaefer ,
Shan Li,
David A. Garcia,
Alok A. Khorana,
Marc Carrier,
Gary H. Lyman
,
Josh J. Carlson ,
Nicole M. Kuderer,
Jordan K. Schaefer ,
Shan Li,
David A. Garcia,
Alok A. Khorana,
Marc Carrier,
Gary H. Lyman
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 